Form 4 filed by Kerr Douglas
Kerr Douglas filed this Form 4 on DYN (Dyne Therapeutics, Inc.) with 2 transaction rows and 0 holding rows, accepted by EDGAR 2026-10-22 20:10:04 UTC.
- Accession
- 0001814189-26-000007
- Filer
- CIK 1814189
- Filed
- 2026-10-22
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: DYN · Dyne Therapeutics, Inc. (CIK 1818794)
- Kerr Douglas officer (Head of R&D and CMO)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-10-20 | A granted | +8,000 | $0 | 170,564 | D |
| Stock option (right to buy) derivative | 2026-10-20 | A granted | +12,000 | $0 | 12,000 | D |